- Trials with a EudraCT protocol (52)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
52 result(s) found for: Simple cells.
Displaying page 1 of 3.
EudraCT Number: 2007-002405-47 | Sponsor Protocol Number: The CogNaive Study | Start Date*: 2007-07-31 |
Sponsor Name:Imperial College | ||
Full Title: A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral r... | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002861-37 | Sponsor Protocol Number: EURABEL-2 | Start Date*: 2007-01-19 |
Sponsor Name:Ziekenhuisapotheek Meppel-Hoogeveen | ||
Full Title: Evaluation of the oral uracil loading test as a sensitive, simple and cheap method to detect DPD deficiency. | ||
Medical condition: Extreme toxicity during of after chemotherapy with a 5-fluorouracil of capecitabine containing regimen for colorectal, breast or head and neck cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003350-80 | Sponsor Protocol Number: APHP190843 | Start Date*: 2020-01-15 |
Sponsor Name:Université de Sherbrooke | ||
Full Title: Lessening Organ Dysfunction with VITamin C (LOVIT) | ||
Medical condition: Sepsis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004779-39 | Sponsor Protocol Number: NH19708 | Start Date*: 2018-02-26 | ||||||||||||||||
Sponsor Name:Roche Farma S.A(Soc unipersonal)que realiza el ensayo en España y que actua como representante F.Hoffmann-La Roche LTD. | ||||||||||||||||||
Full Title: AN OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASCERTAIN THE OPTIMAL STARTING DOSE OF MIRCERA® GIVEN SUBCUTANEOUSLY FOR THE MAINTENANCE TREATMENT OF ANEMIA IN PEDIATRIC PATIENTS WITH CHRONIC KIDNE... | ||||||||||||||||||
Medical condition: Chronic renal anemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) LT (Completed) HU (Completed) FR (Completed) PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003594-95 | Sponsor Protocol Number: MTXSB2018 | Start Date*: 2019-04-30 | ||||||||||||||||
Sponsor Name:Amsterdam UMC location AMC | ||||||||||||||||||
Full Title: Methotrexate to suppress immunogenicity to anti-tumor necrosis factor therapy in IBD patients with loss of response | ||||||||||||||||||
Medical condition: Inflammatory bowel disease: Crohn's disease and Ulcerative colitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001063-23 | Sponsor Protocol Number: 012357 | Start Date*: 2018-06-14 | |||||||||||
Sponsor Name:Queen Mary Innovation Centre, Queen Mary University of London | |||||||||||||
Full Title: PHASE II STUDY ASSESSING THE COMBINED USE OF AUTOLOGOUS BONE MARROW DERIVED MONONUCLEAR CELLS AND G-CSF WITH PERCUTANEOUS CIRCULATORY ASSISTANCE IN THE TREATMENT OF DILATED CARDIOMYOPATHY | |||||||||||||
Medical condition: Heart failure is caused by a cardiomyopathy, which is defined as a disorder of the heart muscle. Dilated cardiomyopathy (DCM) is characterised by enlargement of the ventricles and impaired systolic... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002109-58 | Sponsor Protocol Number: RSR13 RT-016 | Start Date*: 2005-02-14 | |||||||||||
Sponsor Name:ALLOS Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases... | |||||||||||||
Medical condition: Brain metastases from breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) HU (Completed) GB (Completed) LT (Completed) ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000725-12 | Sponsor Protocol Number: Cx601-0303 | Start Date*: 2017-08-08 | |||||||||||
Sponsor Name:TiGenix, S.A.U. | |||||||||||||
Full Title: A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem ce... | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) ES (Completed) HU (Completed) PL (Completed) GB (GB - no longer in EU/EEA) DE (Completed) FR (Completed) SE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002194-22 | Sponsor Protocol Number: A-97-52030-270 | Start Date*: 2014-01-14 | |||||||||||
Sponsor Name:Ipsen Limited | |||||||||||||
Full Title: A Phase IV, Multicentre, Open label, Single Group Exploratory Study to Assess the Clinical Value of Enumeration of Circulating Tumour Cells (CTCs) to Predict Clinical Symptomatic Response and Progr... | |||||||||||||
Medical condition: Symptoms of Neuro Endocrine tumours | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003627-38 | Sponsor Protocol Number: CD-2019/02 | Start Date*: 2019-11-12 | |||||||||||
Sponsor Name:Centre Georges-François Leclerc | |||||||||||||
Full Title: 18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myeloma | |||||||||||||
Medical condition: Patient with multiple myeloma, addressed for initial evaluation and eligible for an autograft of Hematopoietic Stem Cells. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003164-21 | Sponsor Protocol Number: 652-2-203 | Start Date*: 2015-01-05 | |||||||||||
Sponsor Name:Tobira Therapeutics, Inc., a subsidiary of Allergan plc | |||||||||||||
Full Title: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects with Liver Fibrosis | |||||||||||||
Medical condition: Nonalcoholic Steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) IT (Completed) DE (Completed) ES (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004221-41 | Sponsor Protocol Number: BAY1002670/17541 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||||||||||||
Full Title: A randomized, parallel-group, double-blind placebo-controlled and open label active-controlled, multi-center study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids | |||||||||||||||||||||||
Medical condition: Leiomyoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: SE (Completed) DE (Completed) PT (Completed) NL (Completed) GB (Completed) FI (Completed) AT (Completed) CZ (Completed) HU (Completed) LT (Completed) BE (Completed) ES (Completed) PL (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-004352-30 | Sponsor Protocol Number: AB1601 | Start Date*: 2017-05-22 | |||||||||||
Sponsor Name:Araclon Biotech, S.L. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, 24 months Study in Patients with amnestic Mild Cognitive Impairment or Very Mild Alzheimer’s Disease to Investigate the Safety, Tolerabi... | |||||||||||||
Medical condition: Alzheimer's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) SE (Completed) FR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001010-17 | Sponsor Protocol Number: 16SM3217 | Start Date*: 2016-08-26 | ||||||||||||||||
Sponsor Name:Imperial College, London | ||||||||||||||||||
Full Title: Nucleos(t)ide withdrawal in HBeAg negative hepatitis B virus infection to promote HBsAg clearance. (NUC-B) | ||||||||||||||||||
Medical condition: Hepatitis B viral infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006713-16 | Sponsor Protocol Number: CP12-0604 | Start Date*: 2008-09-02 | |||||||||||
Sponsor Name:ImClone Systems Incorporated | |||||||||||||
Full Title: Phase II Randomized, Open-Label Study of IMC-1121B With or Without Dacarbazine in Patients with Metastatic Malignant Melanoma | |||||||||||||
Medical condition: Metastatic Malignant Melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003586-35 | Sponsor Protocol Number: 215336 | Start Date*: 2022-01-25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:GlaxoSmithKline Biologicals SA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A Phase I/II, observer-blind, randomised, placebo controlled, multi-country study to evaluate reactogenicity, safety, immune response, and efficacy of an HSV-targeted immunotherapy in healthy parti... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Recurrent genital herpes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) EE (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003384-24 | Sponsor Protocol Number: NN6535-7519 | Start Date*: 2023-03-08 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A randomised double-blind placebo-controlled clinical study investigating the effects of semaglutide s.c. once-weekly versus placebo on central and peripheral inflammation in participants with Alzh... | |||||||||||||
Medical condition: Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) DK (Trial now transitioned) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002855-48 | Sponsor Protocol Number: BAY1002670/15789 | Start Date*: 2017-07-12 | |||||||||||||||||||||
Sponsor Name:Bayer AG | |||||||||||||||||||||||
Full Title: A randomized, parallel-group, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids | |||||||||||||||||||||||
Medical condition: Leiomyoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: IE (Completed) SE (Completed) CZ (Completed) HU (Prematurely Ended) FI (Completed) AT (Prematurely Ended) NO (Prematurely Ended) DE (Completed) ES (Prematurely Ended) GB (GB - no longer in EU/EEA) DK (Completed) BE (Completed) SK (Completed) LT (Completed) NL (Prematurely Ended) PT (Completed) BG (Completed) IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-001054-96 | Sponsor Protocol Number: 000013/BT | Start Date*: 2020-03-19 | |||||||||||
Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
Full Title: Phase IIb, Placebo-Controlled, Randomized, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB) Single Implantation in Tibial Fracture | |||||||||||||
Medical condition: Tibial fracture considered at risk of DU/NU (based on the combination of risk factors documented to be associated with increased proportion of DU/NU). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Ongoing) DE (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) ES (Ongoing) CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005087-25 | Sponsor Protocol Number: NeoPAN01-2013 | Start Date*: 2014-04-01 | |||||||||||
Sponsor Name:FUNDACION HOSPITAL DE MADRID | |||||||||||||
Full Title: Gemcitabine plus nab-paclitaxel versus folfirinox as neoadjuvant treatment in patients with potentially resectable pancreatic carcinoma. NeoPAN Study | |||||||||||||
Medical condition: Potentially resectable pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
